These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 17476994)
1. Red as a beet. Blumenthal HJ J Okla State Med Assoc; 2007 Apr; 100(4):113. PubMed ID: 17476994 [No Abstract] [Full Text] [Related]
2. Esotropia in a child treated with a scopolamine patch for drooling. Good WV; Crain LS Pediatrics; 1996 Jan; 97(1):126-7. PubMed ID: 8545207 [No Abstract] [Full Text] [Related]
3. Hyperthermia associated with central anticholinergic syndrome caused by a transdermal hyoscine patch in a child with cerebral palsy. Frampton A; Spinks J Emerg Med J; 2005 Sep; 22(9):678-9. PubMed ID: 16113205 [No Abstract] [Full Text] [Related]
4. Visual side-effects from transdermal scopolamine (hyoscine). Firth AY; Walker K Dev Med Child Neurol; 2006 Feb; 48(2):137-8. PubMed ID: 16417670 [TBL] [Abstract][Full Text] [Related]
5. Transderm-induced psychosis in Parkinson's disease. Quinn N Neurology; 2000 May; 54(9):1877. PubMed ID: 10802809 [No Abstract] [Full Text] [Related]
6. Scopolamine: new preparations. Reference treatment for death rattle. Prescrire Int; 2001 Aug; 10(54):99-101. PubMed ID: 11718188 [TBL] [Abstract][Full Text] [Related]
7. Post resuscitation central anticholinergic syndrome. Rizzi RR; Ho J Resuscitation; 2004 Apr; 61(1):101-2. PubMed ID: 15081189 [No Abstract] [Full Text] [Related]
8. An unusual cause of colonic obstruction. Stern JE; Kochman ML Am J Gastroenterol; 2008 Sep; 103(9):2407-9. PubMed ID: 18844634 [No Abstract] [Full Text] [Related]
9. Mental confusion associated with scopolamine patch in elderly with mild cognitive impairment (MCI). Seo SW; Suh MK; Chin J; Na DL Arch Gerontol Geriatr; 2009; 49(2):204-207. PubMed ID: 18834638 [TBL] [Abstract][Full Text] [Related]
10. A comparison of motion sickness remedies in severe sea conditions. Gahlinger PM Wilderness Environ Med; 2000; 11(2):136-7. PubMed ID: 10921365 [No Abstract] [Full Text] [Related]
11. Transdermal scopolamine-induced neurologic deficits in patients with cancer. Friedberg MH; Glantz MJ R I Med; 1994 May; 77(5):141-2. PubMed ID: 8019013 [No Abstract] [Full Text] [Related]
12. The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine. Fredrickson A; Snyder PJ; Cromer J; Thomas E; Lewis M; Maruff P Hum Psychopharmacol; 2008 Jul; 23(5):425-36. PubMed ID: 18421801 [TBL] [Abstract][Full Text] [Related]
13. A case of hyoscine-related oesophagitis. Philcox S; Keegan A Med J Aust; 2007 Jun; 186(12):650-1. PubMed ID: 17576184 [TBL] [Abstract][Full Text] [Related]
17. Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases. Gish P; Mosholder AD; Truffa M; Johann-Liang R J Pediatr; 2009 Sep; 155(3):432-4. PubMed ID: 19732583 [TBL] [Abstract][Full Text] [Related]
18. [Transdermal scopolamine patches and anisocoria]. Roquer JM; Vila A; Roure C Med Clin (Barc); 1995 May; 104(17):677-8. PubMed ID: 7623499 [No Abstract] [Full Text] [Related]
19. Hyoscine skin patches for drooling dilate pupils and impair accommodation: spectacle correction for photophobia and blurred vision may be warranted. Saeed M; Henderson G; Dutton GN Dev Med Child Neurol; 2007 Jun; 49(6):426-8. PubMed ID: 17518927 [TBL] [Abstract][Full Text] [Related]
20. Estradiol replacement in gonadectomized male rats alters scopolamine-induced disruptions of nonspatial learning. Leonard ST; Moerschbaecher JM; Winsauer PJ Exp Clin Psychopharmacol; 2008 Dec; 16(6):532-46. PubMed ID: 19086774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]